As the chairman of Cambridge Therapeutics, John Klein leverages his extensive background in the healthcare and pharmaceutical industries to guide the strategic direction of the company. Outside of his pursuits at Cambridge Therapeutics, John Klein has provided consulting services to Harvard Business School on strategic ways to improve competitiveness.
One program that Harvard Business School offers to students is its annual New Venture Competition. Featuring a $300,000 prize, the competition provides student teams with the opportunity to present a new idea for a business or a social enterprise. To compete in the business track, teams must include at least one current Harvard Business School MBA student to play a lead role in the business and serve as a major equity holder.
For the social enterprise track, teams must consist primarily of Harvard University graduate students who hold meaningful roles in the proposed organization. For social enterprise entries, one team member must meet these qualifications: be a Harvard Business School MBA student, either a Center for Public Leadership fellow or Adrian Cheng fellow, or a Harvard graduate student taking certain courses. In addition to the student competitions, HBS alumni can enter regional New Venture Competitions with cash prizes of $100,000.
